We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Accurate Diagnosis of Obstetric Cholestasis Prevents Fetal Distress

By Labmedica staff writers
Posted on 06 Mar 2008
Obstetric cholestasis is the most common liver disease during pregnancy and can cause serious complications. More...
It causes an increase in the level of bile acids in the blood, which results in severe itching, particularly on the palms and soles of the feet. Dietary fats are not absorbed properly causing vitamin K levels to drop, increasing the risk of excessive bleeding in the mother and baby. Obstetric cholestasis is linked to fetal distress, premature labor, and stillbirth, and therefore, accurate and timely diagnosis is crucial.

A bile acids test is the most sensitive test for obstetric cholestasis. The bile acids level rises in other conditions, however, such as acute fatty liver of pregnancy, hepatitis, and liver cirrhosis. Therefore, liver function tests such as alanine transaminase (ALT), alkaline phosphatase, and gamma glutamyl transpeptidase (GT) are necessary to rule out the possibility of other liver conditions. Randox Laboratories' (Crumlin, UK) fifth-generation bile acids assay can be used to diagnose obstetric cholestasis, combined with the company's full range of liver function tests

Treatment for obstetric cholestasis involves frequent ultrasound scans to monitor for fetal distress. Rest and periodic liver tests are recommended for the mother and medications can alleviate the symptoms. Delivery is often induced at around 37-38 weeks to reduce the risk of stillbirth. Obstetric cholestasis spontaneously resolves after the baby has been delivered; this is confirmed by bile acid levels returning to normal.


Related Links:
Randox

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.